Trump announces 'massive' Japan trade deal including 15% tariff
The two countries have been locked in negotiations for months since Trump launched his global trade offensive, with levies targeting steel and automobiles -- both important Japanese exports -- seen as particular sticking points.
Trump had previously threatened Japan, a major US trading partner, with a tariff of 25 percent beginning August 1 if a deal was not reached.
"We just completed a massive Deal with Japan, perhaps the largest Deal ever made," Trump announced on his Truth Social platform.
He said that under the deal, "Japan will invest, at my direction, $550 Billion Dollars into the United States, which will receive 90% of the Profits."
He did not provide further details on the unusual investment plan, but claimed the deal "will create Hundreds of Thousands of Jobs."
Japanese Prime Minister Shigeru Ishiba said that he needed to examine the deal before commenting.
"As for what to make of the outcome of the negotiations, I am not able to discuss it until after we carefully examine the details of the negotiations and the agreement," Ishiba told reporters in Tokyo after Trump's announcement in Washington.
- Rice imports? -
Japan has agreed to "open their Country to Trade including Cars and Trucks, Rice and certain other Agricultural Products, and other things," Trump said.
Rice imports are a sensitive issue in Japan, and Ishiba's government had previously ruled out any concessions on the topic.
Japan's Nikkei index bounced over one percent on news of the deal, with Japanese auto stocks rising six percent.
The deal comes after Ishiba faced a bruising weekend election that left his coalition without a majority in the upper house.
Trump has been under pressure to wrap up trade pacts after promising a flurry of deals ahead of his August 1 tariff deadline.
Earlier on Tuesday, he announced a deal had been reached with the Philippines which would see the country face 19 percent tariffs on its exports.
The White House also laid out details of a deal with Indonesia, which would see it ease critical mineral export restrictions and also face a 19 percent tariff.
Similar agreements have been struck with the United Kingdom and Vietnam, while negotiations are ongoing with the top three largest US trading partners, China, Canada and Mexico.
After an escalatory tit-for-tat with Beijing, the two major economies agreed to a temporary lowering of tariffs, with another round of negotiations expected next week in Stockholm.
Since returning to the White House in January, Trump has imposed a sweeping 10 percent tariff on allies and competitors alike, alongside steeper levels on steel, aluminum and autos.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Australian
2 hours ago
- The Australian
PH2 proposes Pure One rebrand
Pure Hydrogen proposes name change to Pure One, as it focuses on commercial transport solutions Company's operations set on supply of BEV and HFC vehicles along with hydrogen equipment Introduction of new hybrid coach and rigid truck to provide customers with more options to slash emissions Special Report: Pure Hydrogen is proposing to change its name to Pure One to better reflect its strategic focus on global commercial mobility solutions in the transport sector. The shift from a product-specific name also aligns with the Company's long-term strategy to drive growth through diversified revenue channels without confusing investors or partners. Pure Hydrogen (ASX:PH2) notes its operations have now evolved to comprise the supply of both battery electric and hydrogen fuel cell vehicles, as well as hydrogen equipment such as refuelling solutions and small production facilities built into shipping containers for rapid deployment. In line with its rebrand to Pure One, the Company noted that its Australian operations have been increasingly focused on growing the sales pipeline for its BEVs, which are more commercially viable in the near-term due to lower upfront costs and greater government support. However, it has also secured hydrogen vehicle orders from large customers across the construction, infrastructure, and waste management sectors including TOLL Transport, Heidelberg Materials, Barwon Water and Solo Resource Recovery. In the US and Canadian markets, stronger government subsidies and incentives are accelerating hydrogen vehicle uptake, making HFC solutions commercially attractive with the company being well advanced on several sale and distribution agreements. Shareholder approval for the name change will be sought at the upcoming annual general meeting. Watch: Pure Hydrogen sells zero-emission garbage truck in first US deal Product development PH2 is continuing to update and innovate its product suite in response to evolving customer demand with all of its key vehicle types now available in both hydrogen and electric variants with full Australian Design Rule approvals. As part of its strategic focus on new vehicle rollouts and product development, the Company recently completed the design and engineering works for two new vehicles. The HD100C hybrid coach and TG23 hybrid low cab rigid truck present an affordable entry point to clean energy technology, with price points comparable to traditional diesel variants while offering potential fuel savings of over 35% compared to diesel equivalents. The HD100C hybrid coach. Pic: Pure Hydrogen The company has already received considerable interest from potential buyers interested in incorporating clean energy solutions into their vehicle fleet with minimal disruption to their existing operations. HD100C is a 12-metre vehicle that's expected to appeal to bus operators as its price point is lower than other BEV and HFC buses. TG23 is a 23-tonne hybrid rigid model that combines electric drive with a diesel back-up, making it suitable for regional operations or long-range urban services where charging infrastructure is limited. 'The proposed rebranding to Pure One Corporation reflects our evolving identity and ambitions beyond hydrogen alone, allowing for greater flexibility and clarity as we broaden into a wider clean energy and mobility portfolio,' PH2 managing director Scott Brown said. 'We are pleased with the positive progress made across multiple fronts, including product innovation and a growing sales pipeline that together build strong momentum toward sustainable growth.' 'Our efforts to continually update and diversify the product offering reflect our commitment to meeting varied customer needs globally.' 'Furthermore, Pure remains focused on the execution of its international expansion strategy, led by early traction in North America, which now represents a major addressable market opportunity for the business.' This article was developed in collaboration with Pure Hydrogen, a Stockhead advertiser at the time of publishing. This article does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions.
The Australian
2 hours ago
- The Australian
Prescient raises $9.8m to drive cancer therapies
Investors back Prescient with applications for $3m placement Brings total funds raised from the placement and recent SPP to $9.8m The company will use the funds to support its cancer treatment Special Report: Prescient Therapeutics has raised $3m in a placement to sophisticated and professional investors following a $6.9m SPP for a total $9.8m to advance its pioneering cancer treatment therapies. The clinical stage oncology company will use the funds to support the continued Phase 2 clinical development of its targeted therapy, PTX-100, which is progressing through clinical trials toward potential regulatory approval and access for patients. Two dosage levels of PTX-100 are being evaluated in an open-label design in up to 40 patients with relapsed or refractory cutaneous T-cell lymphoma (CTCL) across multiple sites in Australia, the US and Europe in its current Phase 2a study. CTCL is a rare cancer affecting white blood cells known as T cells, which normally help regulate the immune system. In CTCL, these cancerous T Cells migrate to the skin, where they grow, divide and attack uncontrollably. Treatment options remain limited for patients whose disease has relapsed or become resistant to therapy. On a mission to improve outcomes for cancer patients More than 74m shares are expected to be issued under the placement at 4c per share, the same price as the SPP. Prescient Therapeutics (ASX:PTX) CEO James McDonnell said this marks a significant step forward for the company and empowers the advancement of PTX-100 through Phase 2a development. 'I would like to thank all investors for their support of Prescient and its mission to improve outcomes for cancer patients,' he said. 'We eagerly look forward to the milestones ahead with the potential to turn the Phase 2b clinical study into a pivotal registrational study and setting the stage for PTX-100's potential market entry.' This article was developed in collaboration with Prescient Therapeutics, a Stockhead advertiser at the time of publishing. This article does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions.
The Australian
2 hours ago
- The Australian
LKY secures $5.3m in oversubscribed raise
$5.3 million raised at 9.5c a share in placement Oversubscribed with strong interest from institutional and professional investors Tribeca Investment Partners led raise with cornerstone investment Special Report: A heavily oversubscribed $5.3 million capital raise has validated a US centred critical minerals strategy at the Mojave antimony and rare earths project. Locksley Resources (ASX:LKY) will channel the fresh funding into a new drilling program at Mojave, targeting high-grade antimony and rare earths at the Californian asset. The placement support was spearheaded by Tribeca Investment Partners, a globally recognised resources investment firm, which made a cornerstone investment in LKY during the raise. Locksley chair Nathan Lude said the company was extremely pleased with the level of demand and quality of institutional participation in the placement. 'Having Tribeca cornerstone the raising is a strong endorsement of our strategy and team,' he said. 'In addition, we welcome more than a dozen new institutions to the Locksley register, providing us with a robust group of investors capable of supporting our forward looking growth strategy. 'This funding places us in a strong position to execute our exploration and downstream plans across the Mojave project and unlock the full value of our US based critical minerals portfolio.' More from Locksley Resources: Poised to take advantage of US critical minerals boom from Mojave Mojave antimony and rare earths project Funding from the latest raise will mostly go to exploration, permitting and downstream development for the Mojave project in California. Mojave is directly next door to MP Materials' Mountain Pass rare earths mine, recently subject to two hefty investments from the US Department of Defense and US tech giant Apple. Location of the Mojave project blocks in south-eastern California, USA. Pic: LKY. Mojave's El Campo prospect lies directly along strike from Mountain Pass, while the North Block tenement directly abuts claims held by MP Materials. LKY has also identified potential for antimony and silver in surface sampling, with results up to 46% Sb and 1022g/t Ag. Locksley intends to take advantage of looming rare earth and antimony supply shortages in North America after China moved to restrict exports of the critical minerals in recent years. This article was developed in collaboration with Locksley Resources, a Stockhead advertiser at the time of publishing. This article does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions.
